GlassScriptPhysician profile
Hao Wei Zhang
NPI 1558462424
$40,213.52
in general payments reported to CMS, 2019-2025
98 companies · $7,468 in 2025
The $7,468 reported for 2025 was more than what 86% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,381 · 2020: $3,415 · 2021: $5,323 · 2022: $4,990 · 2023: $6,289 · 2024: $7,348 · 2025: $7,468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19K · Long Term Medical Supply Or Device Loan: $1,629 · Education: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,771.48 |
| Long Term Medical Supply Or Device Loan | $1,629.42 |
| Education | $703.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $5,255.19 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $3,710.50 | 2019-2025 | Lynparza, Enhertu, Calquence |
| Pfizer INC. | $3,294.97 | 2019-2025 | |
| Janssen Biotech, INC. | $3,071.27 | 2019-2025 | Erleada, Darzalex, Tecvayli |
| Dova Pharmaceuticals | $2,033.35 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $1,661.92 | 2019-2025 | Keytruda, Welireg, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $1,367.05 | 2019-2025 | Opdivo, Opdualag, Reblozyl |
| Sobi, INC | $1,064.23 | 2021-2025 | |
| Glaxosmithkline, LLC. | $951.24 | 2020-2025 | Zejula, Jemperli, Ojjaara |
| Incyte Corporation | $926.22 | 2019-2025 | Jakafi, Monjuvi, Niktimvo |
| Celgene Corporation | $879.14 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Amgen INC. | $862.71 | 2019-2023 | Lumakras, Vectibix, Xgeva |
| Lilly USA, LLC | $837.61 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Karyopharm Therapeutics INC. | $778.71 | 2020-2025 | Xpovio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $778.35 | 2019-2025 | Gilotrif |
Show all 98 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $776.00 | 2020-2025 | Tukysa, Adcetris, Tivdak |
| Takeda Pharmaceuticals U.S.A., INC. | $729.36 | 2019-2025 | Fruzaqla, Iclusig, Ninlaro |
| Astellas Pharma US INC | $722.24 | 2019-2025 | Vyloy, Padcev, Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $658.90 | 2019-2025 | |
| Genentech USA, INC. | $612.92 | 2019-2025 | Polivy |
| Gilead Sciences, INC. | $604.91 | 2019-2025 | Trodelvy |
| Exelixis INC. | $603.21 | 2019-2025 | Cabometyx |
| Daiichi Sankyo INC. | $602.72 | 2020-2025 | Enhertu, Datroway |
| Genzyme Corporation | $554.71 | 2019-2025 | |
| Eisai INC. | $546.55 | 2019-2025 | |
| Abbvie INC. | $419.83 | 2019-2025 | Venclexta |
| Array Biopharma INC | $280.58 | 2021-2025 | Braftovi, Mektovi, Lorbrena |
| Tersera Therapeutics LLC | $268.43 | 2020-2025 | Quzyttir, Xermelo |
| Taiho Oncology, INC. | $248.30 | 2019-2023 | |
| Pharmaessentia USA Corporation | $245.66 | 2022-2025 | Besremi |
| Puma Biotechnology, INC. | $240.20 | 2019-2023 | |
| Blueprint Medicines Corporation | $235.51 | 2020-2025 | Ayvakit |
| Jazz Pharmaceuticals INC. | $223.64 | 2019-2025 | |
| Tolmar Pharmaceuticals, INC. | $184.87 | 2020-2022 | |
| Rigel Pharmaceuticals, INC. | $184.83 | 2019-2021 | |
| Immunogen, INC. | $182.18 | 2023 | Elahere |
| Organon LLC | $171.81 | 2021-2025 | Ontruzant |
| Myovant Sciences INC. | $170.11 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $153.58 | 2019-2025 | Ultomiris |
| Progenics Pharmaceuticals, INC. | $151.98 | 2022-2024 | Pylarify |
| Ipsen Biopharmaceuticals, INC | $136.08 | 2023-2025 | Onivyde, Somatuline Depot |
| Foundation Medicine, INC. | $132.65 | 2020 | |
| Emd Serono, INC. | $122.78 | 2020-2025 | |
| Beigene USA, INC. | $113.47 | 2021-2024 | Brukinsa |
| Kite Pharma, INC. | $99.30 | 2020-2023 | |
| Sun Pharmaceutical Industries INC. | $97.67 | 2023-2024 | Yonsa, Odomzo |
| Pharmacyclics LLC, An Abbvie Company | $96.42 | 2021-2023 | Imbruvica |
| Myriad Genetic Laboratories, INC. | $93.31 | 2021-2024 | Myrisk |
| Teva Pharmaceuticals USA, INC. | $89.13 | 2019 | |
| Agios Pharmaceuticals, INC. | $87.35 | 2020-2024 | Pyrukynd |
| Aveo Pharmaceuticals, INC. | $86.25 | 2024-2025 | |
| Adaptive Biotechnologies Corporation | $73.16 | 2023-2024 | Clonoseq |
| Deciphera Pharmaceuticals INC. | $70.35 | 2021-2024 | Qinlock |
| Octapharma USA, INC. | $68.80 | 2020-2021 | |
| Clovis Oncology, INC. | $66.26 | 2019-2020 | |
| Global Blood Therapeutics, INC. | $66.05 | 2021-2022 | |
| Coherus Oncology, INC. | $60.16 | 2022-2024 | |
| Acrotech Biopharma INC. | $59.75 | 2021-2024 | Beleodaq |
| Mylan Institutional INC. | $57.61 | 2019-2022 | |
| Eusa Pharma (US) LLC | $57.20 | 2019-2022 | |
| Syndax Pharmaceuticals, INC. | $56.64 | 2025 | |
| Tempus Ai, INC | $54.84 | 2024 | |
| Stemline Therapeutics INC. | $54.77 | 2023-2024 | Orserdu |
| Tesaro, INC. | $51.86 | 2019 | |
| Secura Bio, INC. | $50.79 | 2020-2024 | Copiktra |
| Morphosys, US INC. | $46.47 | 2022-2023 | Monjuvi |
| Springworks Therapeutics, INC. | $46.35 | 2024-2025 | Ogsiveo |
| Legend Biotech USA INC. | $46.31 | 2024-2025 | Carvykti |
| Ge Healthcare | $45.31 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $44.42 | 2025 | Lynozyfic, Libtayo |
| Novo Nordisk INC | $40.12 | 2021-2023 | Novoseven, Novoeight |
| Mirati Therapeutics, INC. | $39.61 | 2023-2024 | Krazati |
| Azurity Pharmaceuticals, INC. | $39.14 | 2025 | Danziten |
| Tolmar, INC. | $38.39 | 2023 | |
| Telix Pharmaceuticals | $37.50 | 2024 | Illuccix |
| Partner Therapeutics, INC. | $34.81 | 2019 | |
| Novocure INC. | $34.29 | 2024 | Optune Lua (Novottf-200t) |
| Adc Therapeutics America, INC. | $31.48 | 2024 | |
| Genmab U.S., INC. | $29.74 | 2025 | Epkinly |
| West Therapeutics Development, LLC | $29.72 | 2020 | |
| Emmaus Medical, INC. | $29.71 | 2022 | |
| Caris Mpi, INC. | $29.67 | 2025 | Mi Cancer Seek |
| Dendreon Pharmaceuticals LLC | $28.92 | 2024 | Provenge |
| Sumitomo Pharma America, INC. | $28.77 | 2023 | Orgovyx |
| Fennec Pharmaceuticals, INC. | $24.90 | 2023 | Pedmark |
| Iovance Biotherapeutics, INC. | $24.19 | 2025 | Amtagvi |
| Accord Healthcare, INC. | $23.63 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $22.91 | 2019 | |
| Epizyme, INC. | $20.83 | 2021 | |
| Sirtex Medical INC | $20.71 | 2023 | Sir-Spheres Microspheres |
| Clinigen, INC. | $20.44 | 2020 | |
| Shorla Oncology INC. | $19.63 | 2025 | |
| Kyowa Kirin, INC. | $19.15 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.82 | 2020 | |
| Helsinn Therapeutics (U.S.), INC. | $14.04 | 2019 | |
| Spectrum Pharmaceuticals INC. | $13.83 | 2025 | Rolvedon |
| Innate Pharma, INC | $13.40 | 2020 | |
| Pharmaand Gmbh | $12.17 | 2025 | Rubraca |
Drugs and devices associated with these payments
Kisqali $2,087Enhertu $1,019Lynparza $898Keytruda $893Erleada $766Ibrance $760Xtandi $571Reblozyl $566Doptelet $559Xpovio $430Calquence $426Darzalex $421Jakafi $397Tecvayli $387Rybrevant $383Imfinzi $366Verzenio $366Zejula $358Elahere $357Imbruvica $354Tukysa $352Cabometyx $336Carvykti $310Talzenna $293Lenvima $290Balversa $286Akeega $286Opdivo $285Fruzaqla $267Jemperli $257Welireg $255Nubeqa $241Ojjaara $239Jaypirca $221Adcetris $220Opdualag $212Tivdak $207Besremi $205Trodelvy $200Padcev $198Tabrecta $196Braftovi $189Gilotrif $188Mektovi $182Inlyta $180Scemblix $177Quzyttir $172Vyloy $163Orgovyx $163Tagrisso $159Elrexfio $153Talvey $151Iclusig $144Vonjo $141Xofigo $139Lorbrena $137Somatuline Depot $136Onivyde $136Xalkori $130Ontruzant $126Bosulif $126Enjaymo $125Pylarify $123Comirnaty $121Vyxeos $118Ayvakit $108Odomzo $97.67Yonsa $97.67Pluvicto $95.88Epkinly $91.42Fabhalta $90.24Brukinsa $88.07Fotivda $86.25Sarclisa $83.91Polivy $79.54Ninlaro $77.59Promacta $75.84Illuccix $75.00Paxlovid $73.62Clonoseq $73.16Stivarga $71.32Monjuvi $69.08Ultomiris $66.18Pomalyst $65.97Pyrukynd $64.64Vitrakvi $63.98Retevmo $63.30Zepzelca $58.99Qinlock $57.08Orserdu $54.77Oxbryta $54.70Venclexta $53.63Lumakras $53.46Lonsurf $52.18Inqovi $52.18Ogsiveo $46.35Udenyca $39.91Myrisk $39.84Krazati $39.61Danziten $39.14
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hao Wei Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.